For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

N-Gene Research Laboratories, Inc.

USPTO Granted Patents = 14

% Expired Patents = 71.4

EPO Patents = 3

Forward Citations = 49

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Balázs Sümegi (4 out of 7 patents)

Péter Literáti Nagy (3 out of 5 patents)

Zoltán Szilvássy (3 out of 3 patents)

4. Balázs Sümegi (3 out of 3 patents)

5. György Rabloczky (2 out of 2 patents)

6. András Rabloczky, Legal Representative (2 out of 2 patents)

7. Kálmán Tory (2 out of 3 patents)

8. József Mandl (2 out of 2 patents)

9. Mark Anthony Febbraio (1 out of 1 patent)

10. Frances Brenda Lefcort (1 out of 1 patent)

11. László Vígh (1 out of 4 patents)

12. Gábor Balogh (1 out of 14 patents)

13. Sándor Bernáth (1 out of 3 patents)

14. Peter Nagy (1 out of 7 patents)

15. Zoltan Szilvassy (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 11357768 - Methods for treating NASH and for preventing NASH-induced HCC (2022-06-14),

2. 10702514 - Use of BGP15 to treat familial dysautonomia (2020-07-07),

3. 8048873 - Synergistic pharmaceutical combination for the prevention or treatment of diabetes (2011-11-01),

4. 7767694 - Pharmaceutical composition having prokinetic effect (2010-08-03),

5. 7763601 - Prevention and treatment of obesity (2010-07-27),

6. 7635674 - Synergistic pharmaceutical combination for the prevention or treatment of diabetes (2009-12-22),

7. 7151175 - Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same (2006-12-19),

8. 6884424 - Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight (2005-04-26),

9. 6838469 - Pharmaceutical composition that exhibits reduced side-effects comprising O-(3-piperidino-2-hydroxy-1-propyl)nicotinic acid amidoxime and a pyrimidine derivative with known antitumor activity (2005-01-04),

10. 6720337 - Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxlmic acid derivative (2004-04-13),

11. 6656955 - Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivative (2003-12-02),

12. 6500823 - Unsaturated hydroximic acid derivatives as per abstract inhibitors (2002-12-31),

13. 6451851 - Pharmaceutical composition with antiviral activity containing an hydroxymic acid derivative and an antiviral agent (2002-09-17),

14. 6440998 - Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivative (2002-08-27),

Company Overview

N-Gene Research Laboratories, Inc. is a biotechnology firm based in New York, specializing in the development of innovative solutions for genetic research and diagnostics. The company focuses on advancing technologies related to gene editing, molecular biology, and personalized medicine. By leveraging cutting-edge research methodologies, N-Gene aims to enhance the understanding of genetic disorders and improve therapeutic strategies. Their work contributes significantly to the fields of genomics and biotechnology, fostering advancements in healthcare and research applications.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

14 Patents

#531 in New York, NY

#1,296 in New York

#22,333 in US

#42,290 in the World

New York, NY, United States of America

N-Gene Research Laboratories, Inc.

Forward Citations = 49

29 inventors:

Balázs Sümegi (4 out of 7 patents)

Péter Literáti Nagy (3 out of 5 patents)

Zoltán Szilvássy (3 out of 3 patents)

4. Balázs Sümegi (3 out of 3 patents)

5. György Rabloczky (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: N-Gene Research Laboratories, Inc.. Retrieved from https://idiyas.com/company/n-gene-research-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…